Description:

ECOG 3200 Baseline Disease Evaluation Form (RECIST) NCT00025337 Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A16ECDEF-5203-62F8-E034-080020C9C0E0

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A16ECDEF-5203-62F8-E034-080020C9C0E0

Keywords:
Versions (3) ▾
  1. 8/27/12
  2. 5/23/15
  3. 6/3/15
Uploaded on:

June 3, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

ECOG 3200 Baseline Disease Evaluation Form (RECIST) NCT00025337

No Instruction available.

  1. StudyEvent: ECOG 3200 Baseline Disease Evaluation Form (RECIST)
    1. No Instruction available.
Baseline Disease Evaluation

Similar models